Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.
Identifieur interne : 001062 ( PubMed/Curation ); précédent : 001061; suivant : 001063Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.
Auteurs : Xiaobin Zhang [France] ; Joanna Norton [France] ; Isabelle Carrière [France] ; Karen Ritchie [France] ; Isabelle Chaudieu [France] ; Joanne Ryan [France] ; Marie-Laure Ancelin [France]Source :
- Scientific reports [ 2045-2322 ] ; 2017.
Abstract
Generalized anxiety disorder (GAD) is a common chronic condition that is understudied compared to other psychiatric disorders. An altered adrenergic function has been reported in GAD, however direct evidence for genetic susceptibility is missing. This study evaluated the associations of gene variants in adrenergic receptors (ADRs) with GAD, with the involvement of stressful events. Data were obtained from 844 French community-dwelling elderly aged 65 or over. Anxiety disorders were assessed using the Mini-International Neuropsychiatry Interview, according to DSM-IV criteria. Eight single-nucleotide polymorphisms (SNPs) involved with adrenergic function were genotyped; adrenergic receptors alpha(1A) (ADRA1A), alpha(2A) (ADRA2A), and beta2 (ADRB2) and transcription factor TCF7L2. Questionnaires evaluated recent stressful life events as well as early environment during childhood and adolescence. Using multivariate logistic regression analyses four SNPs were significantly associated with GAD. A 4-fold modified risk was found with ADRA1A rs17426222 and rs573514, and ADRB2 rs1042713 which remained significant after Bonferroni correction. Certain variants may moderate the effect of adverse life events on the risk of GAD. Replication in larger samples is needed due to the small case number. This is the first study showing that ADR variants are susceptibility factors for GAD, further highlighting the critical role of the adrenergic nervous system in this disorder.
DOI: 10.1038/srep42676
PubMed: 28198454
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001065
Links to Exploration step
pubmed:28198454Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.</title><author><name sortKey="Zhang, Xiaobin" sort="Zhang, Xiaobin" uniqKey="Zhang X" first="Xiaobin" last="Zhang">Xiaobin Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Norton, Joanna" sort="Norton, Joanna" uniqKey="Norton J" first="Joanna" last="Norton">Joanna Norton</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Carriere, Isabelle" sort="Carriere, Isabelle" uniqKey="Carriere I" first="Isabelle" last="Carrière">Isabelle Carrière</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Ritchie, Karen" sort="Ritchie, Karen" uniqKey="Ritchie K" first="Karen" last="Ritchie">Karen Ritchie</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Chaudieu, Isabelle" sort="Chaudieu, Isabelle" uniqKey="Chaudieu I" first="Isabelle" last="Chaudieu">Isabelle Chaudieu</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Ryan, Joanne" sort="Ryan, Joanne" uniqKey="Ryan J" first="Joanne" last="Ryan">Joanne Ryan</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Ancelin, Marie Laure" sort="Ancelin, Marie Laure" uniqKey="Ancelin M" first="Marie-Laure" last="Ancelin">Marie-Laure Ancelin</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28198454</idno><idno type="pmid">28198454</idno><idno type="doi">10.1038/srep42676</idno><idno type="wicri:Area/PubMed/Corpus">001065</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001065</idno><idno type="wicri:Area/PubMed/Curation">001062</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001062</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.</title><author><name sortKey="Zhang, Xiaobin" sort="Zhang, Xiaobin" uniqKey="Zhang X" first="Xiaobin" last="Zhang">Xiaobin Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Norton, Joanna" sort="Norton, Joanna" uniqKey="Norton J" first="Joanna" last="Norton">Joanna Norton</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Carriere, Isabelle" sort="Carriere, Isabelle" uniqKey="Carriere I" first="Isabelle" last="Carrière">Isabelle Carrière</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Ritchie, Karen" sort="Ritchie, Karen" uniqKey="Ritchie K" first="Karen" last="Ritchie">Karen Ritchie</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Chaudieu, Isabelle" sort="Chaudieu, Isabelle" uniqKey="Chaudieu I" first="Isabelle" last="Chaudieu">Isabelle Chaudieu</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Ryan, Joanne" sort="Ryan, Joanne" uniqKey="Ryan J" first="Joanne" last="Ryan">Joanne Ryan</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author><author><name sortKey="Ancelin, Marie Laure" sort="Ancelin, Marie Laure" uniqKey="Ancelin M" first="Marie-Laure" last="Ancelin">Marie-Laure Ancelin</name><affiliation wicri:level="1"><nlm:affiliation>Inserm, U1061, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Inserm, U1061, Montpellier</wicri:regionArea></affiliation></author></analytic><series><title level="j">Scientific reports</title><idno type="eISSN">2045-2322</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Generalized anxiety disorder (GAD) is a common chronic condition that is understudied compared to other psychiatric disorders. An altered adrenergic function has been reported in GAD, however direct evidence for genetic susceptibility is missing. This study evaluated the associations of gene variants in adrenergic receptors (ADRs) with GAD, with the involvement of stressful events. Data were obtained from 844 French community-dwelling elderly aged 65 or over. Anxiety disorders were assessed using the Mini-International Neuropsychiatry Interview, according to DSM-IV criteria. Eight single-nucleotide polymorphisms (SNPs) involved with adrenergic function were genotyped; adrenergic receptors alpha(1A) (ADRA1A), alpha(2A) (ADRA2A), and beta2 (ADRB2) and transcription factor TCF7L2. Questionnaires evaluated recent stressful life events as well as early environment during childhood and adolescence. Using multivariate logistic regression analyses four SNPs were significantly associated with GAD. A 4-fold modified risk was found with ADRA1A rs17426222 and rs573514, and ADRB2 rs1042713 which remained significant after Bonferroni correction. Certain variants may moderate the effect of adverse life events on the risk of GAD. Replication in larger samples is needed due to the small case number. This is the first study showing that ADR variants are susceptibility factors for GAD, further highlighting the critical role of the adrenergic nervous system in this disorder.</div></front></TEI><pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">28198454</PMID><DateCreated><Year>2017</Year><Month>02</Month><Day>15</Day></DateCreated><DateRevised><Year>2017</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.</ArticleTitle><Pagination><MedlinePgn>42676</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep42676</ELocationID><Abstract><AbstractText>Generalized anxiety disorder (GAD) is a common chronic condition that is understudied compared to other psychiatric disorders. An altered adrenergic function has been reported in GAD, however direct evidence for genetic susceptibility is missing. This study evaluated the associations of gene variants in adrenergic receptors (ADRs) with GAD, with the involvement of stressful events. Data were obtained from 844 French community-dwelling elderly aged 65 or over. Anxiety disorders were assessed using the Mini-International Neuropsychiatry Interview, according to DSM-IV criteria. Eight single-nucleotide polymorphisms (SNPs) involved with adrenergic function were genotyped; adrenergic receptors alpha(1A) (ADRA1A), alpha(2A) (ADRA2A), and beta2 (ADRB2) and transcription factor TCF7L2. Questionnaires evaluated recent stressful life events as well as early environment during childhood and adolescence. Using multivariate logistic regression analyses four SNPs were significantly associated with GAD. A 4-fold modified risk was found with ADRA1A rs17426222 and rs573514, and ADRB2 rs1042713 which remained significant after Bonferroni correction. Certain variants may moderate the effect of adverse life events on the risk of GAD. Replication in larger samples is needed due to the small case number. This is the first study showing that ADR variants are susceptibility factors for GAD, further highlighting the critical role of the adrenergic nervous system in this disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaobin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Mental Health Center, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrière</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudieu</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Disease Epigenetics Group, Murdoch Children's Research Institute, and Department of Paediatrics, The University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ancelin</LastName><ForeName>Marie-Laure</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Inserm, U1061, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Psychiatr Res. 2008 Apr;42(5):384-8</RefSource><PMID Version="1">17408692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA Psychiatry. 2014 Oct;71(10):1174-82</RefSource><PMID Version="1">25162199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychiatry. 2009 Sep;70(9):1281-8</RefSource><PMID Version="1">19573496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Thorax. 2003 Aug;58(8):703-7</RefSource><PMID Version="1">12885990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Psychiatry. 2004 Feb;184:147-52</RefSource><PMID Version="1">14754827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2011 Jul 1;70(1):59-63</RefSource><PMID Version="1">21414605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):227-33</RefSource><PMID Version="1">16526032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2013 Jul;170(7):790-8</RefSource><PMID Version="1">23820832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2002 Nov 15;52(10):1008-30</RefSource><PMID Version="1">12437941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Psychopharmacol. 2011 Jan;26(1):4-11</RefSource><PMID Version="1">21308782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenet Genomics. 2010 Jan;20(1):64-9</RefSource><PMID Version="1">19927042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2013 Jan 30;205(1-2):7-12</RefSource><PMID Version="1">22940547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychopharmacol. 2011 Jan;25(1):78-86</RefSource><PMID Version="1">20093317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2012;18(35):5663-74</RefSource><PMID Version="1">22632471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2005 Sep 15;58(6):435-9</RefSource><PMID Version="1">16043131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Affect Disord. 2015 Feb 1;172:24-9</RefSource><PMID Version="1">25451391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Jul 20;355(3):241-50</RefSource><PMID Version="1">16855264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):341-3</RefSource><PMID Version="1">17034020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2012;18(35):5691-8</RefSource><PMID Version="1">22632468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Oct 31;9(10):e111350</RefSource><PMID Version="1">25360795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatr Genet. 2005 Mar;15(1):7-11</RefSource><PMID Version="1">15722951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2008 Nov;22(11):2383-92</RefSource><PMID Version="1">18599616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2009 Nov;34(12):2517-28</RefSource><PMID Version="1">19641488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Genet Metab. 2000 Sep-Oct;71(1-2):19-31</RefSource><PMID Version="1">11001792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Affect Disord. 2014 Apr;158:114-26</RefSource><PMID Version="1">24655775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2008 Dec;60(4):513-35</RefSource><PMID Version="1">19074621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenomics J. 2010 Feb;10(1):30-9</RefSource><PMID Version="1">19918262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Psychiatry. 2013 Nov 05;3:e322</RefSource><PMID Version="1">24193727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1991;60:653-88</RefSource><PMID Version="1">1652922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroepidemiology. 2003 Nov-Dec;22(6):316-25</RefSource><PMID Version="1">14598854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatr Genet. 2009 Jun;19(3):134-41</RefSource><PMID Version="1">19352218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2015 Jul 30;228(1):150-5</RefSource><PMID Version="1">25983285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Metab. 2015 Mar 17;4(5):365-6</RefSource><PMID Version="1">25973384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychiatr Res. 1975 Nov;12(3):189-98</RefSource><PMID Version="1">1202204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Jun 29;4(6):e6034</RefSource><PMID Version="1">19562039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenomics J. 2007 Feb;7(1):29-37</RefSource><PMID Version="1">16636683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2009 Oct;41(10):1094-9</RefSource><PMID Version="1">19734903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychobiology. 2000;42(2):82-92</RefSource><PMID Version="1">10940763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Genet. 2009 Jan;39(1):15-23</RefSource><PMID Version="1">18855131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Psychiatry. 2015 Mar 31;5:e536</RefSource><PMID Version="1">25826111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2007 Mar;12(3):283-91</RefSource><PMID Version="1">17199132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Genet. 2013 Jan;43(1):13-23</RefSource><PMID Version="1">23229623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Aug 1;162(3):201-11</RefSource><PMID Version="1">15987731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2012 Sep;17(9):887-905</RefSource><PMID Version="1">22584867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cardiovasc Disord. 2008 Dec 23;8:40</RefSource><PMID Version="1">19105822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):1-6</RefSource><PMID Version="1">12555227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroreport. 1998 May 11;9(7):1291-4</RefSource><PMID Version="1">9631415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2003 Apr 1;118B(1):110-4</RefSource><PMID Version="1">12627476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Gen Psychiatry. 2012 Mar;69(3):293-9</RefSource><PMID Version="1">22393221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2012 Jul;61(7):1726-33</RefSource><PMID Version="1">22492527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2010 May;9(5):373-86</RefSource><PMID Version="1">20431569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Mol Biol. 2014 Mar;37(1):15-22</RefSource><PMID Version="1">24688286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Age Ageing. 1998 Nov;27(6):707-14</RefSource><PMID Version="1">10408665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2007 Oct;8(10):749-61</RefSource><PMID Version="1">17726481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Genet. 2003 Jan;33(1):67-72</RefSource><PMID Version="1">12645823</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>01</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28198454</ArticleId><ArticleId IdType="pii">srep42676</ArticleId><ArticleId IdType="doi">10.1038/srep42676</ArticleId><ArticleId IdType="pmc">PMC5309880</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001062 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001062 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:28198454
|texte= Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28198454" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |